Table 1.
Changes of the outcomes.
| Outcomes | COPD (n = 34) |
Other CRD's (n = 49) |
||||
|---|---|---|---|---|---|---|
| n | M2 | Δ | n | M2 | Δ | |
| mMRC, score (0–4) | 34 | 2.6 ± 1.2* | −0.3 ± 0.7 | 46 | 2.0 ± 1.4 | −0.1 ± 0.9 |
| HAD-Anxiety score (0–21) | 34 | 8.2 ± 4.9 | 0.5 ± 3.7 | 46 | 6.8 ± 4.7*** | −2.3 ± 3.7 |
| HAD-Depression, score (0–21) | 34 | 6.8 ± 4.6 | −0.2 ± 5.7 | 46 | 4.4 ± 3.5*** | −1.9 ± 3.3 |
| FAS, score (10–50) | 34 | 25.4 ± 9.3 | −0.4 ± 6.2 | 46 | 21.3 ± 6.9** | −2.7 ± 6.3 |
| VAS (EQ-5D-3L), score (0–100) | 32 | 59.8 ± 22** | 9.8 ± 17.2 | 43 | 66.0 ± 16.3*** | 4.8 ± 24.0 |
| 6MST, strokes | 12 | 409 ± 175*** | 101 ± 66 | 19 | 522 ± 123* | 40 ± 87 |
M0: baseline; M2: end of PR program; n: number of participants at M2; Δ: delta M2–M0; mMRC: modified medical research council dyspnea scale; HAD: hospital anxiety and depression scale; FAS: fatigue assessment scale; VAS: visual-analogue scale; 6MST: 6-minute stepper test; *: P < 0.05; **: P < 0.01; ***: P < 0.001, different from baseline. Data are presented as the mean ± SD.